Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ: IRWD · Real-Time Price · USD
4.700
-0.010 (-0.21%)
At close: Nov 20, 2026, 4:00 PM EST
4.719
+0.019 (0.40%)
After-hours: Nov 20, 2026, 7:43 PM EST
Ironwood Pharmaceuticals Revenue
Ironwood Pharmaceuticals had revenue of $133.04M in the quarter ending September 30, 2026, with 9.00% growth. This brings the company's total for the last twelve months to $400.30M, up 18.09% year-over-year. In the year 2025, Ironwood Pharmaceuticals had annual revenue of $296.15M, down -15.72%. That makes Ironwood Pharmaceuticals the 12,616th largest company in the world by revenue and 2,425th in the United States.
Revenue (ttm)
$400.30M
Revenue Growth
+18.09%
P/S Ratio
1.94
Revenue / Employee
$4,002,960
Employees
100
Market Cap
778.09M
Revenue by Geography
- United States 289.34M 97.7%
- Rest of World 6.81M 2.3%
Fiscal year ended Dec 31, 2025 See the full Ironwood Pharmaceuticals breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 296.15M | -55.26M | -15.72% |
| Dec 31, 2024 | 351.41M | -91.33M | -20.63% |
| Dec 31, 2023 | 442.74M | 32.14M | 7.83% |
| Dec 31, 2022 | 410.60M | -3.16M | -0.76% |
| Dec 31, 2021 | 413.75M | 24.23M | 6.22% |
| Dec 31, 2020 | 389.52M | -38.89M | -9.08% |
| Dec 31, 2019 | 428.41M | 81.77M | 23.59% |
| Dec 31, 2018 | 346.64M | 48.36M | 16.21% |
| Dec 31, 2017 | 298.28M | 24.32M | 8.88% |
| Dec 31, 2016 | 273.96M | 124.40M | 83.18% |
| Dec 31, 2015 | 149.56M | 73.12M | 95.66% |
| Dec 31, 2014 | 76.44M | 53.56M | 234.06% |
| Dec 31, 2013 | 22.88M | -127.36M | -84.77% |
| Dec 31, 2012 | 150.25M | 84.37M | 128.09% |
| Dec 31, 2011 | 65.87M | 22.01M | 50.19% |
| Dec 31, 2010 | 43.86M | 9.54M | 27.78% |
| Dec 31, 2009 | 34.32M | 15.94M | 86.70% |
| Dec 31, 2008 | 18.38M | 7.92M | 75.68% |
| Dec 31, 2007 | 10.46M | 7.32M | 233.25% |
| Dec 31, 2006 | 3.14M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Phibro Animal Health | 1.54B |
| ANI Pharmaceuticals | 1.04B |
| Evotec SE | 815.72M |
| Collegium Pharmaceutical | 815.19M |
| Amphastar Pharmaceuticals | 745.79M |
| Evolus | 325.47M |
| Harrow | 303.25M |
| Cronos Group | 206.20M |
IRWD News
- 15 days ago - Ironwood price target raised to $6 from $5.70 at Craig-Hallum - TheFly
- 16 days ago - Ironwood Pharmaceuticals Earnings Call Transcript: Q3 2026 - Transcripts
- 16 days ago - Ironwood Pharmaceuticals Slides: Q3 2026 - Filings
- 16 days ago - Ironwood Pharmaceuticals Earnings release: Q3 2026 - Filings
- 16 days ago - Ironwood Pharmaceuticals Quarterly report: Q3 2026 - Filings
- 16 days ago - Ironwood reports Q3 EPS 36c, consensus 32c - TheFly
- 16 days ago - Ironwood Pharmaceuticals Raises Full-Year 2026 Financial Guidance Driven by Continued LINZESS U.S. Net Sales Growth and Strong Third Quarter Financial Performance - Business Wire
- 24 days ago - Ironwood Pharmaceuticals to Host Third Quarter 2026 Investor Update Call - Business Wire